MedPath

Efficacy and Safety of "VS002A" With the Standard WHO-ORS in Non-cholera Acute Watery Diarrhea in Infants and Young Children

Not Applicable
Completed
Conditions
Diarrhea, Infantile
Registration Number
NCT04677296
Lead Sponsor
Entrinsic Bioscience Inc.
Brief Summary

Randomized double blinded clinical trial comparing amino acid based oral rehydration solution/medical food and glucose-based oral rehydration solution is infectious diarrhea in pediatric population

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
312
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Duration of diarrhea in hospital (hours)5 days

number of hours of diarrhea after randomization

Secondary Outcome Measures
NameTimeMethod
Total urine output during hospitalization5 days

Total urine output (g/kg body wt.)

Total ORS intake5 days

Amount of intervention drink consumed throughout the duration of the study

Change in body weight (between pre-randomization and post-treatment)5 days

Body weight at randomization and post treatment

ORS intake in the 1st 24 hours of hospitalization1 day

Amount of intervention drink consumed in the first 24 hours after randomization

Stool output1 day

Stool output in the 1st 24 hours of hospitalization (g/kg body wt.), divided into two 12-hour periods

Unscheduled IV (frequency/ORS group)5 days

Frequency of IV fluids between he 2 groups

Treatment failure (frequency/ORS group)5 days

Frequency of treatment failures between the two groups

Urine output in the 1st 24 hours of hospitalization (g/kg body wt.)1 day

Amount of urine in the first 24 hours after randomization

Documented infectious agent5 days

Stool culture and recording of infectious agent causing the diarrhea

Total stool output5 days

Total amount of stool output during the study

Output and frequency of vomiting5 days

Amount and frequency of vomiting between the two groups

Trial Locations

Locations (1)

ICDDR,B

🇧🇩

Dhaka, Bangladesh

ICDDR,B
🇧🇩Dhaka, Bangladesh

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.